Easotic

RSS

hydrocortisone aceponate / miconazole nitrate / gentamicin sulphate

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 06/12/2018

Authorisation details

Product details
Name
Easotic
Agency product number
EMEA/V/C/000140
Active substance
  • hydrocortisone aceponate / miconazole nitrate
  • gentamicin sulphate
International non-proprietary name (INN) or common name
hydrocortisone aceponate / miconazole nitrate / gentamicin sulphate
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QS02CA03
Publication details
Marketing-authorisation holder
Virbac
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
19/11/2008
Contact address

1ère Avenue 2065 m L.I.D.
06516 Carros
France

Product information

26/10/2018 Easotic - EMEA/V/C/000140 - IG/0984

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Otologicals – Corticosteroids and anti infectives in combination

Therapeutic indication

Treatment of acute otitis externa, and acute exacerbation of recurrent otitis externa associated with bacteria susceptible to gentamicin and fungi susceptible to miconazole, in particular Malassezia pachydermatis.

Assessment history

How useful was this page?

Add your rating